Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


July 29, 2015 5:14 PM ET

Pharmaceuticals

Company Overview of PT Tempo Scan Pacific Tbk

Company Overview

PT Tempo Scan Pacific Tbk manufactures, markets, and distributes pharmaceuticals, consumer and household products, and cosmetics in Indonesia and internationally. It operates in three segments: Pharmaceuticals, Personal Care and Cosmetics, and Distribution Services. The company offers consumer health products and prescription/ethical pharmaceutical products under various brand names. It is also involved in the construction and rental of office buildings; provision of advertising and promotion, research and development, computer systems, and distribution and marketing services; pharmaceutical and medical devices trading; and manufacturing of food supplements, food and beverages, and plastic p...

Tempo Scan Tower

16th Floor

Jl. H.R. Rasuna Said, Kav. 3-4

Jakarta,  12950

Indonesia

Founded in 1970

6,000 Employees

Phone:

62 21 2921 8888

Fax:

62 21 2920 9999

Key Executives for PT Tempo Scan Pacific Tbk

PT Tempo Scan Pacific Tbk does not have any Key Executives recorded.

PT Tempo Scan Pacific Tbk Key Developments

PT Tempo Scan Pacific Tbk Reports Consolidated Earnings Results for the Year of 2014

PT Tempo Scan Pacific Tbk reported consolidated earnings results for the year of 2014. For the year, the company’s net sales were able to surpass IDR 7 trillion attributed by much stronger net sales growth rate compared to 2013. Operating profit had registered a decline of 10.5% and it amounted to IDR 678.3 billion, if adjusted for the forex losses then in actual fact, its operating profit had only declined by 1.5%. EBITDA had also decreased by 7.1% and it amounted to IDR 804.7 billion.

PT Tempo Scan Pacific Tbk Reports Earnings Results for the Month, Third Quarter and Year to Date Ended September 2013

PT Tempo Scan Pacific Tbk reported earnings results for the month, third quarter and year to date ended September 2013. For the month, the company net sales amounted to IDR 5,020.4 billion which was accompanied by gradual improvement of its quarterly net sales result amounting to IDR 1,590.5 billion, IDR 1,739.7 billion and IDR 1,690.1 billion during first quarter 2013, second quarter 2013 and third quarter 2013 respectively. Net profit managed to increase by 4.6% and it amounted to IDR 574.6 billion hence its net profit margin was 11.5% or slight improvement compared same period last year net profit margin of 11.4%. Whilst its EBITDA managed to rise by 6.1% and amounted to IDR 749.4 billion, as such EBITDA margin managed to rise to become 14.9% versus previous year EBITDA margin of 14.6%. For the quarter, the company reported net sales growth which grew by 5.3% compared to the corresponding period last year despite challenging market environment. For the year to date, the company reported Net Sales were able to grow by 3.7%, nevertheless such net sales growth rate on adjusted basis to account for one of its Distribution division third party principal which products distribution had been discontinued commencing as of 1 January 2013, then in fact company's September 2013 net sales had grown by 12.4%. Net cash position had risen significantly by 16.0% to become IDR 1,668.8 billion versus its net cash position in the corresponding period last year which stood at IDR 1,439 billion, as a result of its management effort to rigorously control its liquidity position.

PT Tempo Scan Pacific Tbk Reports Earnings Results for the First Half 2013

PT Tempo Scan Pacific Tbk PT reported earnings results for the first half 2013. For the period, net sales grew by 3% year on year and it amounted to IDR 3,330.3 billion. Operating profit was to IDR 489.3 billion. EBITDA had risen by 5.7% and it amounted to IDR 555.2 billion.

Similar Private Companies By Industry

Company Name Region
PT Sinkona Indonesia Lestari Asia
PT CIBA Vision Batam Asia
PT Pradja Pharin Asia
PT. Novell Pharmaceutical Laboratories Asia
PT. Combiphar Asia

Recent Private Companies Transactions

Type
Date
Target
Merger/Acquisition
May 28, 2015
--
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PT Tempo Scan Pacific Tbk, please visit www.thetempogroup.net. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.